Compass announces promising yet modest results from second Phase 3 psilocybin trial; Missouri hearings on ibogaine and psilocybin bills, New Hampshire psilocybin bill advances
Happy Friday and welcome back to The Microdose, an independent journalism newsletter brought to you by the U.C. Berkeley Center for the Science of Psychedelics.
Compass announces promising yet modest results from second Phase 3 trial
On Tuesday, Compass Pathways announced results from COMP006, its second Phase 3 trial using ...
Adverse Events and Psychedelics: Differences Across Substances and Context
Ibogaine is a naturally occurring plant alkaloid and hallucinogen being explored in some contexts as a treatment for substance use disorders and …
Colorado has a chance to get ibogaine policy right
February 17, 2026 3:14 pm. A view of ibogaine extract tincture and iboga root. (Getty Images). As Colorado considers how to regulate ibogaine …
Ibogaine appears to trigger an accelerated “auto-psychotherapy” process during PTSD treatment
A new study published in npj Mental Health Research suggests that U.S. Special Operations veterans treated with a combination of magnesium and ibogaine experience a rapid, self-directed form of psychological healing. The findings suggest that the treatment triggers a state of “auto-psychotherapy,” where patients revisit traumatic memories, reframe their life narratives, and feel a physical sense of brain repair.
Ibogaine is a powerful psychoactive substance derived from the ...